p53 protein and gene alterations in pathological stage C prostate carcinoma

Journal of Urology

Volumn 158, Issue 2, 1997, Pages 510-514

  Salem, Carol E ^a   Tomasic, Nickolas A ^a   Elmajian, Donald A ^a   Esrig, David ^a   Nichols, Peter W ^a   Taylor, Clive R ^a   Skinner, Donald G ^a   Roy Burman, Pradip ^a   Lieskovsky, Gary ^a   Cote, Richard J ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Carcinoma; Genes; Prostate; Prostatic neoplasms; Protein p53

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER RISK; CANCER STAGING; CELL PROLIFERATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA;

EID: 0030814799     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)64520-8     Document Type: Article

References (37)

1. Levine, A. J., Momand, J. and Finlay, C. A.: The p53 tumour suppressor gene. Nature, 351: 453, 1991.
2. Lane, D. P.: Cancer. p53 Guardian of the genome. Nature, 358: 15, 1992.
3. Esrig, D., Spruck, C. H., III, Nichols, P. W., Chaiwun, B., Steven, K., Groshen, S., Chen, S. C., Skinner, D. G., Jones, P. A. and Cote, R. J.: p53 Nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Amer. J. Path., 143: 1389, 1993.
4. Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Nakamura, Y., White, R., Smits, A. M. and Bos, J. L.: Genetic alterations during colorectaltumor development. New Engl. J. Med., 319: 525, 1988.
5. Davidoff, A. M., Humphrey, P. A., Iglehart, J. D. and Marks, J. R.: Genetic basis for p53 overexpression in human breast cancer. Proc. Natl. Acad. Sci., 88: 5006, 1991.
6. Yokota, J., Wada, M., Shimosato, Y., Terada, M. and Sugimara, T.: Loss of heterozygosity on chromosome 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc. Natl. Acad. Sci., 84: 9252, 1987.
7. Visakorpi, T., Kallioniemi, O. P., Heikkinen, A., Koivula, T. and Isola, J.: Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J. Natl. Cancer Inst., 84: 883, 1992.
8. Thompson, S. J., Mellon, K., Charlton, R. G., Marsh, C., Robinson, M. and Neal, D. E.: P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia. Brit. J. Urol., 69: 609, 1992.
9. Bookstein, R., MacGrogen, D., Hilsenbeck, S. G., Sharkey, F. and Allred, D. C.: p53 Is mutated in a subset of advanced-stage prostate cancers. Cancer Res., 53: 3369, 1993.
10. Mirchandani, D., Zheng, J., Miller, G. J., Ghosh, A. K., Shibata, D. K., Cote, R. J. and Roy-Burman, P.: Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. Amer. J. Path., 147: 92, 1995.
11. Aprikian, A. G., Sarkis, A. S., Fair, W. R., Zhang, Z.-F., Fuks, Z. and Cordon-Cardo, C.: Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. J. Urol., 151: 1276, 1994.
12. Voeller, H. J., Sugars, L. Y., Pretlow, T. and Gelmann, E. P.: p53 Oncogene mutations in human prostate cancer specimens. J. Urol., 151: 492, 1994.
13. Navone, N. M., Troncoso, P., Pisters, L. L., Goodrow, T. L., Palmer, J. L., Nichols, W. W., von Eschenbach, A. C. and Conti, C. J.: p53 Accumulation and gene mutation in the progression of human prostate carcinoma. J. Natl. Cancer Inst., 85: 1657, 1993.
14. Konishi, N., Hiasa, Y., Hayashi, I., Matsuda, H., Tsuzuki, T., Ming, T., Kitahori, Y., Shiraishi, T., Yatani, R. and Shimazaki, J.: p53 Mutations occur in clinical, but not latent, human prostate carcinoma. Jap. J. Cancer Res., 86: 57, 1995.
15. Gleason, D. F.: Histologic grading and clinical staging of prostatic carcinoma. In: Urologic Pathology. The Prostate. Edited by M. Tannenbaum. Philadelphia: Lea and Febiger, pp. 171-198, 1977.
16. Gibbons, R. P., Cole, B. S., Richardson, R. G., Correa, R. J., Jr., Brannen, G. E., Mason, J. T., Taylor, W. J., and Hafermann, M. D.: Adjuvant radiotherapy following radical prostatectomy: results and complications. J. Urol., 135: 65, 1986.
17. Bostwick, D. G. and Brawer, M. K.: Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer, 59: 788, 1987.
18. Garcia, R. L., Coltrera, M. D. and Gown, A. M.: Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed embedded tissues. Comparison with flow cytometric analysis. Amer. J. Path., 134: 733, 1989.
19. Bravo, R., Frank, R., Blundell, P. A., and MacDonald-Bravo, M.: Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature, 326: 515, 1987.
20. Shi, S. R., Key, M. E. and Kalra, K. L.: Antigen retrieval in formalin-fixed paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39: 741, 1991.
21. Kaplan, E. and Meier, P.: Non-parametric estimation from incomplete observations. J. Amer. Stat. Ass., 53: 457, 1958.
22. Mehta, C. R. and Patel, N. R.: A network algorithm for performing Fisher's exact test in R X C contingency tables. J. Amer. Stat. Ass., 78: 427, 1983.
23. Hirji, K. F., Mehta, C. R. and Patel, N. R.: Computing distributions for exact logistic regression. J. Amer. Stat. Ass., 82: 1110, 1987.
24. Davidoff, A. M., Kerns, B. M., Iglehart, J. D. and Marks, J. R.: Maintenance of p53 alterations throughout breast cancer progression. Cancer Res., 51: 2605, 1991.
25. Spruck, C. H., III, Ohneseit, P. F., Gonzalez-Zulueta, M., Esrig, D., Miyao, N., Tsai, Y. C., Lerner, S. P., Schmutte, C., Yang, A. S. and Cote, R.: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54: 784, 1994.
26. Nuorva, K., Soini, Y., Kamel, D., Autio-Harmainen, H., Risteli, L., Risteli, J., Vahakangas, K. and Paakko, P.: Concurrent p53 expression in bronchial dysplasias and squamus cell lung carcinomas. Amer. J. Path., 142: 725, 1993.
27. Flejou, J. F., Potet, F., Muzeau, F., Le Pelletier, F., Fekete, F. and Henin, D.: Overexpression of p53 protein in Barrett's syndrome with malignant transformation. J. Clin. Path., 46: 330, 1993.
28. Yin, J., Harpaz, N., Tong, Y., Huang, Y., Laurin, J., Greenwald, B. D., Hontanosas, M., Newkirk, C. and Meltzer, S. J.: p53 Point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology, 104: 1633, 1993.
29. Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L. and Vogelstein, B.: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature, 358: 80, 1992.
30. Rodrigues, N. R., Rowan, A., Smith, M. E., Kerr, I. B., Bodmer, W. F., Gannon, J. V. and Lane, D. P.: p53 Mutations in colorectal cancer. Proc. Natl. Acad. Sci., 87: 7555, 1990.
31. Dinjens, W. N., van der Weiden, M. M., Schroeder, F. H., Bosman, F. T. and Trapman, J.: Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer. Int. J. Cancer, 56: 630, 1994.
32. Fox, S. B., Persad, R. A., Royds, J., Kore, R. N., Silcocks, P. B. and Collins, C. C.: p53 And c-myc expression in stage A1 prostatic adenocarcinoma: useful prognostic determinants? J. Urol., 150: 490, 1993.
33. Van Veldhuizen, P. J., Sadasivan, R., Garcia, F., Austenfeld, M. S. and Stephens, R. L.: Mutant p53 expression in prostate carcinoma. Prostate, 22: 23, 1993.
34. Nagle, R. B., Brawer, M. K., Kittelson, J. and Clark, V.: Phenotypic relationships of prostatic intraepithelial neoplasia to invasive prostatic carcinoma. Amer. J. Path., 138: 119, 1991.
35. Brawer, M. K.: Prostatic intraepithelial neoplasia: a premalignant lesion. Hum. Path., 23: 242, 1992.
36. McNeal, J. E. and Bostwick, D. G.: Intraductal dysplasia: a premalignant lesion of the prostate. Hum. Path., 17: 64, 1986.
37. Konishi, N., Hiasa, Y., Matsuda, H., Tao, M., Tsuzulii, T., Hayashi, I., Kitahori, Y., Shiraishi, T., Yatani, R., Shimazaki, J. and Lin, J.: Intratumor cellular heterogeneity and alterations in ras and p53 tumor suppressor gene in human prostate carcinoma. Amer. J. Path., 147: 1112, 1996.